<DOC>
	<DOCNO>NCT02827201</DOCNO>
	<brief_summary>The main objective trial evaluate every 2 month alternate nab-paclitaxel/gemcitabine FOLFIRI.3 versus nab-paclitaxel + gemcitabine , regard progression disease 6 month .</brief_summary>
	<brief_title>FIrst Line Treatment Metastatic Pancreatic Cancer : Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Histological cytological confirmation pancreatic adenocarcinoma Distant metastatic disease Scan ( MRI scanner contraindicate ) complete within 3 week start treatment At least one lesion measurable RECIST v1.1 criterion Life expectancy &gt; 3 month No previous chemotherapy ( adjuvant chemotherapy gemcitabine authorise administered 6 month prior inclusion ) No previous radiotherapy ( unless least one measurable target lesion outside irradiation zone ) Pain must monitor inclusion 18 year &lt; age &lt; 75 Performance status : WHO &lt; 2 ANC ≥ 1500/mm3 , platelet ≥ 100 000/mm3 , haemoglobin ≥ 9 g/dL ASAT ( SGOT ) , ALAT ( SGPT ) ≤ 2.5 x ULN ≤ 5 x ULN liver metastasis find Bilirubin ≤ 1.5 x ULN ( patient drain retrograde technique includable ) , creatinine &lt; 120 μmol/L , MDRD creatinine clearance &gt; 60 mL/min Women childbearing age must negative pregnancy test ( β HCG ) start treatment Women childbearing age well men ( sexual intercourse woman childbearing age ) must agree use effective contraception without interruption duration treatment 6 month administration last treatment dose Patient affiliate social security scheme Patient information signature inform consent Other type pancreatic tumour , especially endocrine acinar cell tumours Ampulloma Presence meningeal cerebral metastasis , bone metastases Gilbert 's syndrome Presence neuropathy &gt; grade 1 accord NCICCTC 4.0 Contraindications specific study treatment History chronic diarrhoea inflammatory disease colon rectum , unresolved occlusion subocclusion symptomatic treatment administer Other concomitant cancer history cancer 5 year , exception carcinoma situ cervix basal cell squamous cell carcinoma , consider cured Significant history heart respiratory disease , include history interstitial pneumonia Patient already include another clinical trial experimental molecule Women breastfeed Persons deprive liberty guardianship Unable submit medical monitoring trial due geographical , social psychological reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>pancreatic cancer</keyword>
</DOC>